|
GB202015944D0
|
|
Universal riboswitch for inducible gene expression
|
|
WO2021028585A1
|
|
Bacterium comprising myo-inositol to propionate pathway
|
|
WO2021015616A1
|
|
Lrr-rlkii receptor kinase interaction domains
|
|
GB202010348D0
|
|
Base editing tools
|
|
WO2020256553A1
|
|
Type iii crispr/cas-based diagnostics
|
|
WO2020242313A1
|
|
One step procedure for producing a protein oleogel
|
|
WO2020115181A1
|
|
Methods of genetically altering a plant nin-gene to be responsive to cytokinin
|
|
WO2020094828A1
|
|
Microbial hosts engineered for increased tolerance to temperature shifts
|
|
GB201909597D0
|
|
Crispr type v-u1 system from mycobacterium mucogenicum and uses thereof
|
|
WO2019226050A2
|
|
Novel viral anti-infective reagents
|
|
EP3727325A1
|
|
Method for the preparation of dried oleosomes
|
|
GB201815820D0
|
|
Off-target activity inhibitors for guided endonucleases
|
|
GB201805023D0
|
|
Mosquito attractants
|
|
WO2018172331A1
|
|
Diterminal oxidation of alkanes
|
|
WO2018109101A1
|
|
Thermostable cas9 nucleases
|
|
WO2018099719A1
|
|
Alcohol acetyl transferases for alkyl alkanoate production
|
|
WO2018083128A2
|
|
Microbial genome editing
|
|
GB201716590D0
|
|
Thermostable cas9 nucleases with reduced off-target activity
|
|
WO2018060263A1
|
|
Nanofluidic device, fluidic system and method for performing a test
|
|
US2019292537A1
|
|
Prokaryotic Argonaute Proteins and Uses Thereof
|
